The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Chimerix Inc. shares valued at $23,470 were purchased by Meyer Robert J. on May 19. At $2.06 per share, Meyer Robert J. acquired 11,400 shares. The insider’s holdings grew to 26,400 shares worth approximately $48048.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Also, MIDDLETON FRED A purchased 20,000 shares, netting a total of over 40,738 in proceeds. Following the buying of shares at $2.04 each, the insider now holds 20,000 shares.
Before that, Andriole Michael T. had added 15,000 shares to its account. In a trade valued at $25,635, the Chief Business Officer and CFO bought Chimerix Inc. shares for $1.71 each. Upon closing the transaction, the insider’s holdings increased to 15,000 shares, worth approximately $0.39 million.
As published in their initiating research note from Maxim Group on April 29, 2021, Chimerix Inc. [CMRX] has been a Buy and the price target has been revised to $20. This represents a 90.9% premium over Thursday’s closing price. As of March 31, 2021, Wedbush has initiated its “an Outperform” rating for CMRX. Earlier on March 31, 2021, Jefferies initiated its rating. Their recommendation was “a Buy” for CMRX stock.
Analyzing CMRX’s Price Performance
On Thursday, Chimerix Inc. [NASDAQ: CMRX] rose 12.35% to $1.82. The stock’s lowest price that day was $1.64, but it reached a high of $1.82 in the same session. During the last five days, there has been a surge of approximately 32.85%. Over the course of the year, Chimerix Inc. shares have dropped approximately -71.70%. Shares of the company reached a 52-week high of $7.0200 on 01/04/22 and a 52-week low of $1.2700 on 06/16/22. A 50-day SMA is recorded $3.0720, while a 200-day SMA reached $5.1469. Nevertheless, trading volume fell to 2.26 million shares from 2.56 million shares the previous day.
Support And Resistance Levels for Chimerix Inc. (CMRX)
According to the 24-hour chart, there is a support level at 1.7000, which, if violated, would cause prices to drop to 1.5800. In the upper region, resistance lies at 1.8800. The next price resistance is at 1.9400. RSI (Relative Strength Index) is 43.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0543, which suggests the price will decrease in the coming days. Percent R is at 15.38%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Chimerix Inc. subject to short interest?
Stocks of Chimerix Inc. saw a sharp rise in short interest on May 30, 2022 jumping by 0.13 million shares to 4.81 million. Data from Yahoo Finance shows that the short interest on Apr 28, 2022 was 4.68 million shares. A jump of 2.7% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.72 of the overall float, the days-to-cover ratio (short ratio) jumped to 0.72.
Which companies own the most shares of Chimerix Inc. (CMRX)?
According to Opaleye Management, Inc. filings, the company currently owns 5,903,450 shares, which is about 6.75% of the total CMRX shares outstanding. The investor’s shares have appreciated by 323,450 from its previous 13-F filing of 5580000.0 shares. With the completion of the buy transaction, Suvretta Capital Management LLC’s stake is now worth $9,302,240. BlackRock Fund Advisors reduced a -0.25% interest valued at $9.15 million while Rubric Capital Management LP sold a 0 stake. A total of 568,498 shares of Chimerix Inc. were sold by SSgA Funds Management, Inc. during the quarter, and -357,801 were sold by Point72 Asset Management LP. In its current portfolio, The Vanguard Group, Inc. holds 3,674,783 shares valued at $6.91 million.
In terms of Chimerix Inc. share price expectations, FactSet research, analysts set an average price target of $8.00 in the next 12 months, up nearly 393.83% from the previous closing price of $1.62. Analysts anticipate Chimerix Inc. stock to reach $11.00 by 2022, with the lowest price target being $5.00. In spite of this, 5 analysts ranked Chimerix Inc. stock as a Buy at the end of 2022.